Molecular mimicry: Structural camouflage of proteins and nucleic acids  by Tsonis, Panagiotis A. & Dwivedi, Bhakti
Available online at www.sciencedirect.com
Biochimica et Biophysica Acta 1783 (2008) 177–187
www.elsevier.com/locate/bbamcrReview
Molecular mimicry: Structural camouflage of proteins and nucleic acids
Panagiotis A. Tsonis ⁎, Bhakti Dwivedi
Department of Biology and Center for Tissue Regeneration and Engineering, University of Dayton, Dayton, OH 45469-2320, USA
Received 3 October 2007; received in revised form 5 November 2007; accepted 6 November 2007
Available online 17 November 2007Abstract
When it comes to protein specificity and function their three-dimensional structure is the ultimate determinant. Thus, sequences that participate
in key parts, such as catalytic sites or DNA binding have been favored and maintained highly conserved during evolution. However, in a reversal
of fortune, selection has favored conservation of shapes over sequence, especially when proteins look like nucleic acids. Proteins from pathogens
evade the host's defenses because they are shaped as DNA; others use such a disguise for transcriptional regulation. Several factors are tRNA
look-alikes so that they can efficiently control the process of protein synthesis. Molecular mimicry among RNAs could result in a new unexplored
level in gene regulation. This comprehensive review outlines this important area and aims to emphasize that molecular mimicry could in fact be
more widespread than initially thought and eventually adds a new layer of genetic regulation.
© 2007 Elsevier B.V. All rights reserved.Keywords: Molecular mimicry; Protein–DNA; RNA–tRNA; Protein–tRNAAn unsuspecting fish swims by a piece of tree bark, a fallen
leaf and forest debris. It seems like a very natural environment
for the Amazon and Orinoco river basins. But alas! It is the last
scenery the fish will ever see! The tree bark is the shell, the leaf
is the head and neck and the debris is the loose skin of the
matamata turtle (Fig. 1a), which feeds on this fish [1]. It is called
camouflage, but in reality the turtle's body has been selected to
mimic its environment in order to give it an advantage over prey
or predators. Such an ‘environmental’ mimicry can be seen in
many different animals, such as the Malaysian leaf frog (whose
name implies that it looks like a leaf; Fig. 1b) or the walking
stick (Fig. 1c), an insect that looks like an ordinary twig and
thus, fools its predators, which pass by and ignore it.
The evolution of camouflage is certainly a very interesting
but poorly studied phenomenon, which favors animals that in
shape and colorization resemble their surrounding environment.
So, it should not be surprising that such a strategy has been
exploited at the molecular level as well. Molecular mimicry
between proteins is a well documented event, where bacteria,
viruses or parasites evade the immune response, agonists and
antagonists bind to receptors, or when an autoimmune response
is initiated because a pathogen shares sequence similarities with⁎ Corresponding author. Tel.: +1 937 2292579.
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doi:10.1016/j.bbamcr.2007.11.001native proteins [2,3]. Protein–protein mimicry results because
similar amino acid sequences are present in different proteins
and it should not be surprising that it exists. The topic of protein–
protein mimicry is beyond the scope of this review. Here we are
concernedwith molecular mimicry between proteins and nucleic
acids, which are completely different molecules. This mimicry
relates to domains of proteins that have assumed a very similar
three-dimensional structure to nucleic acids, DNA or RNA [4].
Such mimicry as we will see serves a good purpose either for
survival or for function during several processes, such as rep-
lication, transcription, splicing and protein synthesis. We will
also cover mimicry among different RNA molecules because it
can also illustrate quite nicely the advantage of the strategy as
well as the impact that this might have in gene regulation.
1. Proteins disguised as DNA
Whya protein should evolve looking likeDNA?Thebest guess
would be because it fools other proteins that normally bind DNA.
The advantage of this is obviouswhen such a protein is encoded by
an invading genome.Theunique structural features of double helix
DNA include negatively charged phosphate groups joining two
adjacent nucleotides, diverse major and minor grooves, nucleo-
tides that provide either polar or hydrophobic nature. An effective
DNA mimic usually presents a surface that is complementary in
Fig. 1. Examples of camouflage in animals. a: Matamata turtle (Chelus fimbriatus), b: Malaysian leaf frog (Megophrys montana) [1]. Courtesy of M. Blum
www.undersea3d.com. c: Walking stick (Diapheromera femorata). Photo was obtained from the website: http://home.comcast.net/~zirschkyd/walkingstick.
html.
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These DNA mimics aim towards DNA-binding proteins and thus
act as DNA molecule [5,6].
1.1. How pathogens use mimicry to battle the host defenses
and survive
1.1.1. Protecting the genome
One of the first examples of DNA mimicry by a protein was
ocr, which stands for ‘overcome classical restriction.’ This is a
bacteriophage T7 protein, which is expressed after the phage
infects E. coli. Bacteria usually protect themselves from foreign
DNA by means of restriction enzymes. In this context, the ocr
protein competitively inhibits type I DNA restriction enzymes
from binding to their DNA target, thereby allowing a successful
phage propagation through the bacterial population and thus
acts as antirestriction protein [7–15]. In addition to type I
restriction enzymes, ocr also binds to E. coli RNA polymerase
[16]. The shape of ocr is an elongated 26 kDa dimeric protein
[9,14,17], which suggest structural similarity to the DNA and
thus complementarity to the binding groove on the target
protein [18–20]. X-ray crystallographic structure of ocr reveals
a remarkable molecular mimicry of 24 bp of bent B-form DNA
[21]. The distribution of carboxylic groups on the surface of the
protein mimics the distribution of phosphate groups on target
DNA (Fig. 2a). Also, the distinctive bend in the ocr structure is
similar to the bend induced in DNA upon binding to type Irestriction enzyme. It has also been shown that ocr can inhibit
all known families of type I restriction enzymes, regardless of
their target DNA sequence [21]. Besides ocr, other antirestric-
tion proteins such as T3 phage SAMase protein and Ard family
proteins also seem to be potential DNA mimics [12,22–25].
The Bacillus subtilis bacteriophage genome contains uracil
instead of thymine and upon infection its genome is targeted by
the key DNA repair enzyme uracil-DNA glycosylase (UDG).
To counter, the phage expresses uracil-DNA glycosylase inhi-
bitor (Ugi), a protein that protects the uracil containing phage
DNA by irreversibly inhibiting the host's UDG. In comparing
the three-dimensional structures of UDG-bound DNA [26]
(Fig. 2b) and UDG–Ugi [27] (Fig. 2b′) we can see that DNA
and Ugi bind the UDG's active site. This suggests mimicry
between DNA and Ugi. Thus, Ugi protects the phage's DNA by
competitively binding to UDG's active site. True enough when
the β1 strand of Ugi is structurally superimposed with DNA
the conserved acidic residues align with the phosphate groups
(as shown in Fig. 2c).
Another protein that could be a DNA mimic is HI1450 from
Heamophilus influenza. The mimicry is largely inferred by its
structural similarity to Ugi [28]. As we can see in Fig. 2c the
HI1450β1 strand also aligns with the DNA backbonemimicking
part of the minor groove. Recently, it has been shown that HI1450
binds to a dsDNA-binding protein HU-α and that this interaction
is mediated by residues in the β1 strand [29]. HU-α is a histone-
like protein in H. influenza that is involved in gene regulation,
Fig. 2. Pathogen proteins that mimic DNA. a: Bacteriophage T7 ocr. Superimposition of phosphate groups of 12 bp B-DNA onto the 12 carboxyl groups of ocr dimer
(in blue ribbon form with dimer interface shown as red line). The phosphate groups are colored yellow (phosphorus) and purple (oxygen). The carboxyl groups are
colored red (oxygen) and black (carbon). The sugar backbones of DNA helix are shown in two green shades. The base pairs are not shown for clarity. The black lines
represent the direction of fitted DNA [21]. b: UDG–dsDNA and b′: UDG–Ugi complex: The E. coli UDG (blue) is bound to DNA (green sticks), in b and to Ugi
(brown) in b′ [85]. The arrow points to the interacting β1 strand. c: Structural alignment of β1 strands of HI1450 (blue) and Ugi (red) with dsDNA. The conserved
acidic residues are labeled and highlighted along the strand. The dsDNA is shown in yellow with the phosphate groups colored and labeled in green [86]. d: The
proposed model of E. coli gyrase (GyrA59)–DNA complex [87]. The DNA duplex is shown in green and red ribbons and the active site tyrosine is denoted by a yellow
star. d′: The proposed model of E. coli gyrase (GyrA59)–MfpA complex [39]. MfpA is shown in green. In both figures, E. coli gyrase is represented as surface.
Surfaces are colored according to electrostatic charge distribution, blue for positive and red for negative. Figures are courtesy of Cell Press (a,b,b′), Wiley and Sons (c),
Nature Publishing Group (d) and AAAS (d′).
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dence strongly supports the view that HI1450 may act as a DNA
mimic and could have a major role in inhibiting or regulating the
nucleoid protein. Similar distribution of glutamate and aspartateresidues can be seen in DinI protein from E. coli [33]. DNA
damage prevents replication by DNA polymerase, resulting in the
formation of single-stranded DNA (ssDNA). The binding of the
Rec protein to ssDNA induces a DNA repair process known as
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response bymimicking ssDNA [33]. Biochemical studies suggest
that DinI can prevent ssDNA binding to RecA and can also
stabilize the ssDNA–RecA cofilaments [35,36]. DinI seems to
regulate RecA by competing with ssDNA for the same binding
site of RecA molecule [33,37].
1.1.2. Drug resistance
One of the drugs that are used to fight tuberculosis is
fluoroquinolone. This drug inhibits bacterial DNA replication by
binding reversibly to the gyrase–DNA complex, thereby causing
all sorts of topological problems. Gyrase is a bacterial type II
topoisomerase, which mediates catenation and decatenation of
double-stranded DNA. As one would expect, the infectious bac-
teria often become resistant to drugs through mutations in the
gyrase itself, weakening the binding of the drug while retainingFig. 3. Protein–DNA mimicry at transcriptional level. a: Karyopherin α (Kapα50) i
Kapα50 arms are colored in orange. The SV40 Tantigen peptides are shown in blue [4
polymerase subunits-αI, αII, β, β′ and ω are colored in light blue, dark blue, orange
gray and pink respectively and σ factor subunits are shown in yellow ribbons and sph
diamonds indicate location of probes used in the study. c: TBP-binding domain of D
and TAFII230 as surface. c′: TBP-binding surface of the TATA box (surface) in the
Asp-78 with cytosine. d′: G-C interaction in dsDNA [49]. Cytosines are shown in b
Figures are courtesy of Cell Press.enough gyrase activity for bacterial survival. MfpA protein,
however, provides an alternative resistance mechanism to fluo-
roquinolone. It competes with DNA for the gyrase surface thus
protecting gyrase from fluoroquinolone until the enzyme has
completed its function. MfpA is a member of the penta-peptide
repeat family of bacterial proteins, where every fifth amino acid is
either leucine or phenylalanine [38]. The structure of MfpA is a
dimer composed of a right handed β helix with a size, shape and
charge distribution remarkably similar to B-formDNA [39]. Even
though, the exact mechanism of interaction between MfpA and
gyrase is not known, studies imply that MfpA might be mimic-
king a 30 bp segment ofB-formDNAand thus could be capable of
a direct interaction with gyrase [39] (as shown in Fig. 2d and d′).
It has been suggested that other proteins of the penta-peptide
repeat family could function as inhibitors of DNA binding by a
similar mechanism as MfpA inhibition of gyrase [40].n complex with SV40 T antigen NLS peptide. The conserved residues of H3 of
1]. b, b′: The positions of σ factor, before and after DNA binding [43]. The RNA
, green and gray respectively. The template and non-template DNA are shown in
eres. In b′ the β′ pincers are rotated 16° into the active center. White circles and
rosophila TAFII230 in the TBP–TAFII complex. TBP is shown as green ribbon
TBA–TATA complex [46]. d: Interaction between the Rho residues Arg-66 and
lue and residues from Rho pairing with cytosines are in black (stereo images).
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1.2.1. Shuttling factors to the nucleus
Selective nuclear transport is mediated by nuclear localiza-
tion signals (NLSs) and transport factors as karyopherins or
importins. The structure of karyopherin α is composed of ten
tandem arm repeats, which form a twisted helical shape with a
large groove [41] as shown in Fig. 3a. The structure of karyo-
pherin α indicates a DNA double helix mimic, however, it has a
larger rise per helical turn. NLSs peptides of several other
nuclear proteins are known to be involved in DNA binding in
the nucleus, for example NLS of transcription factor LEF-1
specifically binds to the major groove of cognate DNA [42].
Interestingly, NLS peptides can also bind to several lysine and
arginine residues of the large groove of karyopherin α [41].
Therefore, it has been proposed that the nuclear import factors
such as karyopherin α have NLS-binding sites that mimic DNA
targets in the nucleus (Fig. 3a). DNA mimicry by karyopherin
α might also have some role in importing functional transcrip-
tion factors into the nucleus by mimicking their DNA-binding
sites.
1.2.2. RNA polymerase recruitment to the promoter
The prokaryotic RNA polymerase (holoenzyme) is com-
posed of five subunits (β,β′ two α and ω) along with the σ
factor. The σ factor is responsible for directing the polymerase
to the promoter region. Once transcription has become pro-
cessive the σ factor dissociates from the complex. When theFig. 4. RNA–tRNA mimicry. a: LSU intron (red) is superimposed with tRNATyr (b
acceptor stem and anticodon indicated, original picture obtained from www.cytograp
Note the pseudoknot at the acceptor site. d:BMV tRNA-like structure [54]. The eight tRNA
mimic the amino acid acceptor stem and anticodon respectively. e: TMV tRNA-like structu
central core (labeled as C). The acceptor stem and anticodon are mimicked by domains Dstructure of RNA polymerase was examined it was found that
the σ factor's position was different in the holoenzyme (before
DNA binding) and in the open complex (bound to DNA) as
shown in Fig. 3b and b′ respectively. In fact, in the holoenzyme
the 1.1 subunit of the σ factor occupied the region within the
active center cleft where DNA is placed in the open form [43]. In
other words, theσ1.1 subunit is a DNAmimic and corresponds to
the downstream location of the DNA in the open complex. In
order for the open complex to be formed, σ1.1 must be displaced.
These structural data explain why deletion of σ1.1 affects the
kinetics but not the stability of the open complex [44,45].
The eukaryotic RNA polymerase II is recruited to the
promoter region with the orchestrated action of the basal
apparatus that is composed of many different factors. The first
to contact the TATA box in the promoter region is TFIID,
which is composed of the TATA binding protein (TBP) and
several TBP-associated factors (TAFs). In order for the TBP to
become active it must be relieved from TAFs and this is
mediated by the recruitment of TFIIB. TAFs have a
characteristic structure that mimics DNA double helix thus
blocking the binding of TBP to TATA box. The solution
structure of Drosophila TBP–TAFII230 complex [46] shows
remarkable similarities with the TBP–TATA box complex
[47,48] (Fig. 3c and c′). The arch-shaped surface of TAFII 230
is similar to partially unwound minor groove of TATA bound to
TBP. Both TAFII 230 and the TATA box have an extensive
hydrophobic surface. In addition, the negative charged side
chains of TAFII 230 mimic the positions of phosphate groupslue), with the sites protected by aaRS shown in yellow [50]. b: tRNA with its
hica.com/animations/. c: Valylatable tymoviral TYMV tRNA-like structure [54].
-like structural domains are labeled (A,B1,B2,B3,C,D,E, F).DomainsAandB2–3
re [54]. The three tRNA-like domains are indicated asD1,D2 andD3, connected by a
1 and D2, respectively. Figures courtesy of Cell Press (a) and Springer (b–e).
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TAFII 230 is that the TATA box surface is highly symmetric,
whereas the TAFII 230 surface is asymmetric. This asymmetryresults in closer matching of surface charges and hydrophobi-
city between TAFII 230 and TBP. This implies a direct
inhibition of TBP interaction with the TATA box and thus
183P.A. Tsonis, B. Dwivedi / Biochimica et Biophysica Acta 1783 (2008) 177–187regulating gene expression. As in the case of σ1.1 displacement
to form the open complex described above, such DNA mimics
provide an obvious competition for regulation by activators or
repressors.
1.2.3. Termination
In prokaryotes, transcription ends by two different processes,
the Rho-independent and the Rho-dependent one. As the RNA
polymerase transcribes the end of the unit, the sequences at the
3′ end can form a stem and loop structure. In the Rho-inde-
pendent termination this structure can induce by itself the
opening of the flap and the transcript falls off the RNA poly-
merase. In other cases termination has to be mediated by Rho.
Rho is a protein with ATPase and helicase activity. Also, it has
three strong nucleic acid-binding sites with a preference for
pyrimidines. The three-dimensional structure of Rho bound to
an oligo-C sequence reveals that the interaction of a cytosine
with Rho's amino acids mimics the interaction of C-G in DNA
(Fig. 3d and d′), explaining, thus, the preference of Rho for
pyrimidines [49].
2. RNAs disguised as tRNAs
tRNAs are key players in protein synthesis. The 3-D struc-
ture of tRNA is a clover leaf L-shape with an anticodon at one
end and an amino acid acceptor at the other end. The acceptor
site is recognized by the aminoacyl-tRNA synthetases, which
charge each tRNA with its cognate amino acid. This site inter-
acts with the peptidyl transferase center of the ribosome
allowing the formation of peptide bonds. The anticodon is the
sequence that interacts with the codons of the mRNA an inter-
action that is crucial to the decoding process. However, the
tRNA structure has many look-alikes. They can be found in
other RNA structures or even in proteins.
2.1. Splicing
Studies of mtRNA splicing in Neurospora crassa and in
yeast have pinpointed aminoacyl-tRNA synthetases (aaRSs)
and other RNA-binding proteins that have adopted a function in
group I splicing. Most likely these proteins recognize structures
in group I introns that resemble their RNA-binding sites. In the
case of N. crassa it seems that tyrosyl-tRNA synthetase is
“fooled” and recognizes a tRNA-like structural motif in two
(LSU and ND1) group I intron's catalytic cores [50]. Obviously,
the catalytic core of these ribozymes is folded in a similar
fashion as a tRNA. Such an association has evolved as a
splicing mechanism of these introns. When LSU and tRNATyr
are superimposed it is evident that domain L9 aligns with the
acceptor stem, domain P7 with the variable loop (V) and
domains P4/P6 with the anticodon stem (Fig. 4a).Fig. 5. Protein–tRNA mimicry. a: Thermus thermophilus RRF, yeast Phe-tRNAPhe, T
and human eRF1. Atoms are colored — red (oxygen), green (carbon), blue (nitrogen
relevant numbers [81]. b: The binding of paromomycin onto helix 44 (H44) and its rol
(blue) in the 40S subunit with respect to eEF2 (gray), c′: The interaction between phosph
the sugar phosphate backbone of A192 and A1493 of helix 44 [73]. Figures are court2.2. Helping viruses to replicate
Another set of RNAs that resemble tRNA, the so-called tRNA-
like structures (TLS) has been found at the 3′ of many genomic
RNA plant viruses (for reviews see [51–55]). The tRNA-binding
domains can be charged with three different amino acids, valine,
tyrosine, or histidine, a reaction very similar to the aminoacylation
of canonical tRNAs. In addition, the folded tRNA-binding do-
mains are structurally very similar to the canonical tRNA except
the pseudoknotted amino accepting stem, which is unique to all
viral tRNA mimics (Fig. 4b–e). This pseudoknot is equivalent to
the amino acid acceptor branch of tRNA. The amino acid acceptor
branch of canonical tRNAs is composed of 12 bp (7 from acceptor
stem and 5 fromT-stem). However, in Turnip yellowmosaic virus
(TYMV) RNA it is formed from three helical segments each
with a specified number of nucleotides [56,57] (Fig. 4c). Unlike
TYMV tRNA-like domain, Brome mosaic virus (BMV) and
Tobacco mosaic virus (TMV) RNA (Fig. 4d and e) do not show a
clear L-shape cover leaf architecture of tRNA [58,59]. It has been
shown that TLS are required for virus viability [60] and are also
crucial for gene expression [61,62]. Recently, it has been found
that valylated TLS of TYMVentraps ribosomes and directs them
to the internal initiation of translation (with the valineN-terminally
incorporated) for protein synthesis [63]. Removal of TLSTYMV
completely abolishes polypeptide synthesis. One of the major
explanationswhy these RNAs have adapted a tRNA-like structure
as well as aminoacylation is because replication of these viruses'
RNA genome requires interactions with a translation elongation
factor [64,65]. Support for this comes from results indicating that
aminoacylated viral RNAs can interact with elongation factors
EF-Tu and EF-1a and that EF-Tu is a part of the bacteriophageQβ
RNA replicase. The mimicry has been evolved to reflect the
surface of the elongator tRNAs that normally bind to elongation
factors, thus, allowing efficient replication of the viral genome.
3. Proteins disguised as tRNA
This kind of mimicry is perhaps the most widespread and
striking. Since tRNAs are major players in proteins synthesis,
their mimics are also involved in this process. The charged tRNA
enters the A-site of the ribosome bound to EF-Tu. In there the
tRNA has two tasks, one is the decoding, by the interaction of the
anticodon and the mRNA's codon, and the other is the peptide
bonding at its acceptor site. After this cycle, the tRNA-peptide
translocates to the P-site leaving the A-site empty for the next
tRNA. The translocation is facilitated by another elongation
factor, EF-G.When a stop codon is located at the A-site, signaling
the end of translation, it is recognized by a new factor, the release
factor (RF). This factor is able to release the polypeptide from the
tRNA. After this and the removal of RF the ribosomal subunits
must dissociate, because if stayed as is unspecific translation canhermus aquaticus EF-Tu:GDP:Phe-tRNAPhe, Thermus thermophilus EF-G:GDP
), and yellow (phosphorus or sulfur) and protein domains are shown with their
e in H44 codon–anticodon interactions. c: Localization of ETA (orange) and H44
ates of ETA-boundβTAD and eEF2 (DIPH; a modified histidine) is very similar to
esy of Springer (a), Dr. V. Ramakrishnan (b) and Nature Publishing Group (c,c′).
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From this short trip to protein synthesis we can see that the A-site
of the ribosome is visited andmust be occupied (except by tRNA)
by several proteins. The accommodation of tRNAs as they move
from the A- to the P-site is very specific, thus if any protein is to
occupy the same place it must have the shape and the size of a
tRNA. The result is the incredible molecular mimicry between
tRNA, EF-G,RF andRRF [66–71] (Fig. 5a). In Fig. 5awe can see
how the EF-Tu-bound tRNA looks very similar in size and shape
with EF-G and RF. Also, the structural similarity between tRNA
and RRF is spectacular (see also below). The interesting case here
is that all these different proteins do not share any significant
sequence homologies with each other, they are unrelated proteins.
Molecular mimicry can also account for the action of anti-
biotics, whose one major target is protein synthesis [72]. For
decoding and recognition of the codon by the tRNA a significant
conformational change must occur in helix 44 of the small sub-
unit, which is at the heart of the decoding center. Two universally
conserved amino acids A1492 and A1493 (E. coli numbering)
must be flipped out. This costly rearrangementmakes sure that the
cognate tRNA will be recognized. Antibiotics bind that exact
place and result in flipped A1492 and A1493 (see Fig. 5b). Thus,
the conformation for tRNA and codon recognition is available
without cost, resulting in non-cognate tRNA recognition, which
in turn results in incorporation of the wrong amino acids and
mutated proteins. A similar strategy has been devised by exotoxin
A (ETA) from Pseudomonas aeruginosa in order to achieve
universal recognition of its substrate eEF2 (Fig. 5c and c′) [73].
Notably, the toxin-bound βTAB (a non-hydrolysable NAD+
analog) presents its phosphates to its target residue of eEF2 in an
orientation that coincides with the phosphate backbones of A1492
andA1493. Thus, this mimicrymaximizesPseudomonas' survival
chances because any resistance to its toxin by the target organism
would entail mutations in eEF2, which is crucial for function.
4. Insights into the mimicry issues
This review outlines how structural molecular mimicry can be
used as strategy for one particular regulation or another. The
obvious conclusion for the use of such mimicry is that if a protein
looks like, say tRNA, it must do something that a tRNA does
(at least structurally). However, we must stress here that this does
not necessarily have to hold at the functional level as well. A good
example is the structure and function of RF and RRF. RFs contain
a GGQ motif that is responsible for hydrolysis (the equivalent of
CCA in tRNA) and a tripeptide (PA/VT in RF1 and SPF in RF2)
that mimics the anticodon and are responsible for discriminating
against the different stop codons. The distance of the tripeptide
and the GGQ in the crystal structures of isolated RF1 and RF2,
however, is not compatible with the distance between the de-
coding and the peptidyl transferase center [74]. When the
structure of ribosome-bound RF2 was visualized by cryo-EM
reconstructions, it was shown that RF2 undergoes changes in
relation to the isolated structure. This allowed for accommodation
of the tripeptide in the decoding center of the 30S subunit [75,76].
However, more details were received when the structure of
ribosome-bound RF1 and RF2 were solved via X-ray crystal-lographywith a resolution that allowed the protein helices and the
backbone of RNAs to be resolved. It was then found that the tip of
α5 helix (not part of the tripeptide tRNA mimic but common to
both factors) could act as a discriminator of nucleotides at position
1 and that the tripeptide-containing anticodon loop, which is
specific to RF1 and RF2, could recognize bases 2 and 3 [77]. The
conclusion is that recognition of stop codons involves other
elements apart from the anticodon tripeptide mimic. Similar
situations can be argued with the mimicry of the ribosome
recycling factor (RRF). Structural studies have shown that despite
the similar structure and dimensions to tRNA, RRF's orientation
on the ribosome is different than those of tRNA and the tRNA
mimicking domains of EF-G [78]. The studies on RFs and RRF
reveal that structural mimicry is one aspect of molecular mimicry
and functional mimicry is another. This underscores the
importance to understand the biological significance behind
structural mimicry. In this respect we can have two layers of
mimicry. One is purely structural and has a strict topological
aspect. In other words, for a protein to occupy a space normally
occupied by tRNA it has to look like it or at least should have very
similar dimensions. Once this has been achieved the protein has to
do a task. In the case of RF it has to recognize a codon and
hydrolyze the peptide bond (as a tRNAdoes). This second layer is
a functional mimicry and the protein components mediating this
do not have to look structurally like tRNA. For mimics that are
used for competition (such as TBP), functionalmimicrymight not
be that important, but for mimics that also perform a function
(such as catalysis) it must involve other elements of the protein or
the interacting environment. How do we approach these issues
experimentally? In the case of tRNAmimics they have to interact
with other ribosomal components. Detailed studies on inter-
molecular interactions as derived from X-ray crystallographic
data of the different mimics could identify possible common
threads. Or if these are unique they will extend our knowledge
about functional mimicry. It is also important to learn more about
these interactions as a function of time, which can be achieved by
other emerging technologies, such as hydrogen exchange coupled
tomass spectrometry (MS).When a protein is placed in deuterium
solution, hydrogen atoms are exchanged with deuterium atoms.
Protein mass increase is then measured with high-resolution MS
and the place of deuterium incorporation is determined in peptide
fragments.With such a method protein dynamics and movements
can be studied after binding and over time [79]. This might
provide global signatures that can be attributed to structural or
functional mimics. Another insight can be obtained by comparing
evolution of sequences of DNA or RNA mimics. Are there
common motifs that might account for structural mimicry? Such
studies have not really been attempted largely because obvious
sequence similarities have not been noticed. However, it might be
possible to identify common signatures. For example, it is well
established that a small number of amino acids (such as arginine,
lysine, asparagine, glutamic acid) are the main participants with
DNA interactions. It could be possible to identify such signatures
that might indicate mimicry, but we seriously doubt that this will
be definite. After all, these amino acids are also specifically
interacting with DNA mediating the function of DNA-binding
proteins aside from mimics as well [80].
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Molecular mimicry must be an ancient mechanism that
probably originated in the RNA world, where specific three-
dimensional structures conferred unique functions to different
RNAs [81]. It is easy to imagine that similarly shaped RNAs
would have common partners and such an association might
have been maintained during the transition to RNA–protein and
DNA–protein world.
Natural selection has resulted in animal camouflage for their
advantage. As we discussed in the beginning of the review in
many cases looking like something else is a good survival
strategy. Molecular mimicry has evolved for several different
reasons. One is the obvious survival benefit as it is highlighted
in cases where pathogens use molecular mimicry to fool
the host's defenses and survive. Another reason should be the
acquisition of more efficient function. This is reflected quite
well in the molecular mimicry of factors involved in protein
synthesis. In this process evolution has favored proteins that
look like tRNAs so that they perform well within the
constrains of size and shape that are imposed by the ribosome.
In this case there is selection for shape and not necessarily
for sequences. RFs, RRF and EF-G do not share sequence
homology.
Another very important reason, we believe, is competition in
gene regulation. A good example here is the competition of
TAFs for the TATA box, which is the main promoter regulatory
element. Such mimicry for regulatory purposes could be much
more widespread than we know or appreciate. RNAs can fold in
many different structures due to complimentarity of nucleotide
sequences. Thus, structures could be more accessible for mi-
micking. For example, ribosomal protein S15 recognizes both
the 16S rRNA and mRNA. The recognition is possible by
molecular mimicry of 16S rRNA and mRNA. The sites that are
required for S15 binding assume similar conformations [82].
Similar mimicry could also be the case involving other ribo-
somal proteins as well as regulation of gene expression by
threonyl-tRNA synthetase. Except from its enzymatic role in
aminoacylation, threonyl-tRNA synthetase regulates its own
mRNA expression by binding to the operator. The operator has
a conformation mimicking the anticodon arm structure [83].
A different example for mimicry-directed regulation is the
spliceosome's U1A protein, which binds to both U1 snRNA
and its own 3′UTR [84]. Given the plethora of RNA structures,
we anticipate that molecular mimicry must play a much more
pivotal role in regulation than previously suspected. The exam-
ples of molecular mimicry that we have so far could only reflect
the tip of an iceberg. As more structural studies become avail-
able, especially those involving interactions of proteins and
RNA, molecular mimicry could take a more prominent role in
genetic regulation and evolution.
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